SFA — Sopharma AD Cashflow Statement
0.000.00%
Last trade - 00:00
- BGN995.22m
- BGN1.15bn
- BGN1.89bn
- 35
- 61
- 50
- 44
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -121 | -134 | -148 | -145 | -170 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -128 | -179 | -76 | 110 | 45 |
Capital Expenditures | -40.4 | -27 | -27.1 | -23.7 | -43.3 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -63.8 | 28.5 | -41 | -40 | -19.6 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -104 | 1.5 | -68.1 | -63.6 | -62.9 |
Financing Cash Flow Items | 203 | 243 | 204 | 30.6 | -0.513 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 236 | 176 | 157 | -64.3 | 127 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.23 | -2.22 | 12.6 | -17.9 | 109 |